Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleZoledronic Acid Dosing Interval for Metastatic Cancer-Reply.AuthorsHimelstein, Andrew L.; Loprinzi, Charles L.; Shapiro, Charles L.SubjectsZOLEDRONIC acid; MULTIPLE myeloma treatment; BONE tumors; BREAST tumors; DIPHOSPHONATES; IMIDAZOLES; TUMORSPublicationJAMA: Journal of the American Medical Association, 2017, Vol 317, Issue 14, p1478ISSN0098-7484Publication typeletterDOI10.1001/jama.2017.2566